Monitor for the actual Form 4 filing to confirm whether the sale was executed. A director selling a small position after an option exercise is routine and not indicative of negative sentiment.
Price Chart
Executive Summary
Director George Simeon filed a Form 144 notice to sell 14,514 shares of CRISPR Therapeutics common stock, with an estimated aggregate market value of approximately $720,373. The shares were acquired via stock option exercise on the same date. This is a relatively small sale relative to the company's market cap and likely a routine diversification trade by a director.
Key Facts
- Director George Simeon filed Form 144 to sell 14,514 shares of CRISPR Therapeutics common stock.
- Estimated aggregate market value of the proposed sale is approximately $720,373.
- Shares were acquired via stock option exercise on October 14, 2026.
- The sale is small relative to the company's market cap (~$97M based on the filing's implied price of ~$49.63/share).
- The filing is an advance notice of intent to sell, not a completed transaction.
Financial Impact
Proposed sale of 14,514 shares worth approximately $720,373 — less than 0.01% of the company's market cap.
Risk Factors
- The sale may still be executed, but the small size makes it unlikely to move the stock.
- No other insider selling patterns are present in this filing to suggest a broader trend.
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001950047-26-010218 |
| Document: 0001950047-26-010218-index.html | 0001950047-26-010218 |
| Document: 0001950047-26-010218.txt | 0001950047-26-010218 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 20, 2026 6d ago | Insider Cluster | $50.50 | awaiting T+20 | — | $49.39 (+2.20%) |
Oct 19, 2026 7d ago | 8-K | $49.88 | awaiting T+20 | — | $49.39 (−0.98%) |
Oct 16, 2026 10d ago | Insider Cluster | $50.04 | awaiting T+20 | — | $49.39 (−1.30%) |
Oct 16, 2026 10d ago | Insider Cluster | $50.04 | awaiting T+20 | — | $49.39 (+1.30%) |
Oct 15, 2026 11d ago | Insider Cluster | $49.25 | awaiting T+20 | — | $49.39 (+0.28%) |
Oct 14, 2026 12d ago | 144 | $51.52 | awaiting T+20 | — | $49.39 (−4.13%) |
Oct 6, 2026 20d ago | 144 | $52.35 | awaiting T+20 | — | $49.39 (−5.65%) |
Sep 24, 2026 4w ago | Insider Cluster | $54.23 $49.39 | ▲ +8.92% | ▲ +7.45% | $49.39 (+8.92%) |
Aug 28, 2026 8w ago | Press Release | $57.72 $54.23 | ▼ −6.05% | ▼ −6.56% | $49.39 (−14.43%) |
Aug 3, 2026 12w ago | Press Release | $53.07 $56.82 | ▲ +7.07% | ▲ +8.30% | $49.39 (−6.93%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers